Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Director departure
Appointed director
Quarterly results
Consulting agrmnt
Employment agrmnt
Asset disposition

REPROS THERAPEUTICS INC. (RPRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2019 SC 13G/A Rosalind Advisors, Inc. reports a 0% stake in Repros Therapeutics Inc.
02/13/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2018 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
02/07/2018 EFFECT Form EFFECT - Notice of Effectiveness:
02/07/2018 EFFECT Form EFFECT - Notice of Effectiveness:
02/07/2018 EFFECT Form EFFECT - Notice of Effectiveness:
02/07/2018 EFFECT Form EFFECT - Notice of Effectiveness:
02/07/2018 EFFECT Form EFFECT - Notice of Effectiveness:
01/31/2018 4 Wyllie Michael (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 21,580 shares @ $0.67, valued at $14.5k
Disposed/sold 27,779 shares @ $0.67, valued at $18.6k
Disposed/sold 5,000 options @ $0.32, valued at $1.6k
01/31/2018 4 FOURTEAU PATRICK (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 12,221 shares @ $0.67, valued at $8.2k
Disposed/sold 27,779 shares @ $0.67, valued at $18.6k
Disposed/sold 5,000 options @ $0.32, valued at $1.6k
01/31/2018 4 Ramasastry Saira (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 12,221 shares @ $0.67, valued at $8.2k
Disposed/sold 27,779 shares @ $0.67, valued at $18.6k
Disposed/sold 5,000 options @ $0.32, valued at $1.6k
01/31/2018 4 Masterson Nola E (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 12,221 shares @ $0.67, valued at $8.2k
Disposed/sold 27,779 shares @ $0.67, valued at $18.6k
Disposed/sold 5,000 options @ $0.32, valued at $1.6k
01/31/2018 4 CAIN DANIEL F (Director) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 23,221 shares @ $0.67, valued at $15.6k
Disposed/sold 27,779 shares @ $0.67, valued at $18.6k
Disposed/sold 5,000 options @ $0.32, valued at $1.6k
01/31/2018 4 Anderson Katherine (CFO) has filed a Form 4 on REPROS THERAPEUTICS INC.
Txns: Unknown transaction of 83,875 shares @ $0.67, valued at $56.2k
01/31/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/31/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/31/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/31/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/31/2018 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
01/31/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/31/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/31/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/31/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/31/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
01/31/2018 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of Repros Therapeutic, Inc.",
"Amended and Restated Bylaws of Repros Therapeutic, Inc."
01/31/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
01/30/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
01/30/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/26/2018 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements:
01/26/2018 8-K Other Events
Docs: "Repros Announces Negative Opinion From the EMA for Enclomiphene"
01/19/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
01/05/2018 SC 14D9/A Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
01/05/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
01/03/2018 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy